Evaluation of recombinant activated factor VII, prothrombin complex concentrate and fibrinogen concentrate to reverse apixaban in a rabbit model

Authors :: Anne-Céline Martin
B. Le Bonniec
Anne Godier
Thomas Lecompte
Joseph Emmerich
Charles-Marc Samama
Source :: European Journal of Anaesthesiology. 29:94-95
Publication Year :: 2012
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2012.

Subjects :: business.industry
Fibrinogen
Prothrombin complex concentrate
law.invention
Anesthesiology and Pain Medicine
Biochemistry
law
Activated factor VII
Recombinant DNA
Rabbit model
Medicine
Apixaban
business
medicine.drug

Full Text Access

Tools